Maintenance rTMS for Depression (Maitr-De)

This study is looking at how well different types of repetitive Transcranial Magnetic Stimulation (rTMS) can help people with Major Depressive Disorder or Treatment Resistant Depression stay well after they've already responded to rTMS treatment. rTMS uses magnetic pulses to stimulate brain cells. The study compares two active rTMS approaches, "standard maintenance rTMS" and "clustered maintenance rTMS," to a "sham maintenance rTMS" (a placebo treatment). Researchers want to see how these treatments affect brain connections (DLPFC-SGC connectivity) over six months. You could join if you are 18 to 80 years old, have responded to rTMS for depression, and meet other specific criteria. The study aims to enroll 75 participants across three sites.

Study design
This is a double-blind, three-arm maintenance treatment trial involving 75 participants. Participants will be randomly assigned to receive one of the three rTMS treatments.
What's involved
Participants will receive either standard, clustered, or sham maintenance rTMS over a 6-month period. The study will measure brain connections at 6 months.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 6 months, indicating a follow-up period of at least that duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06938841

Maintenance rTMS for Depression (Maitr-De)

Recruiting
NAAges 18–80InterventionalTreatment
University of California, San Diego
~75 participants
Updated 2026-04-29 on ClinicalTrials.gov
What's tested:Transcranial Magnetic Stimulation (TMS) - Standard maintenance rTMS:Transcranial Magnetic Stimulation (TMS) - Clustered maintenance rTMS:Transcranial Magnetic Stimulation (TMS) -- Sham maintenance rTMS

At a glance

Recruiting sites
3 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Aim: To evaluate the effects of two active rTMS maintenance treatments (i.e., standard and clustered) compared to sham maintenance rTMS on DLPFC-SGC connectivity.
Measured over 6-months
Major Depressive Disorder
Treatment Resistant Depression
3 sites across 3 states
California1
New York1
Australian Capital Territory1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Exclusion

1\. Pregnancy 2. History of or current psychotic disorder or depression with psychotic features 3. Severe borderline personality disorder based on clinical assessment. 4. Diagnosis of Intellectual Disability or Autism Spectrum Disorder 5. Current moderate or severe substance use disorder or demonstrating signs of acute substance withdrawal 6. Clinically significant suicidal ideation with plan 7. Any history of ECT (greater than 8 sessions) without a clinical meaningful response in the current episode.
  • Aim: To evaluate the effects of two active rTMS maintenance treatments (i.e., standard and clustered) compared to sham maintenance rTMS on DLPFC-SGC connectivity.6-months

    Our primary aim is to examine the efficacy of maintenance rTMS on sustaining connectivity between the dorsolateral prefrontal cortex (DLPFC) and subgenual cingulate cortex (SGC) measured through concurrent TMS and electroencephalography (TMS-EEG) at baseline and every six weeks throughout the 6-month treatment period